Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 8, 2011, Pages 1245-1253

  Zhang, Youxue ^a   Yao, Lei ^a   Zhang, Xianyu ^a   Ji, Hongfei ^a   Wang, Lihong ^a   Sun, Shanshan ^a   Pang, Da ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Immunohistochemistry; Prognosis; USP22

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEINASE; UBIQUITIN SPECIFIC PROTEASE 22; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FIBROADENOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; THIOLESTER HYDROLASES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 79961170767     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-0998-9     Document Type: Article

References (29)

1. AY Amerik M Hochstrasser 2004 Mechanism and function of deubiquitinating enzymes Biochim Biophys Acta 1695 1-3 189 207 15571815 10.1016/j.bbamcr.2004.10. 003 1:CAS:528:DC%2BD2cXhtVantbzF (Pubitemid 39574973)
2. SL Berger 2007 The complex language of chromatin regulation during transcription Nature 447 7143 407 412 17522673 10.1038/nature05915 1:CAS:528:DC%2BD2sXlsFOgsrc%3D (Pubitemid 46816746)
3. JE Bolden MJ Peart RW Johnstone 2006 Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 9 769 784 16955068 10.1038/nrd2133 1:CAS:528:DC%2BD28XptVCltrY%3D (Pubitemid 44348499)
4. C Bouchard O Dittrich A Kiermaier K Dohmann A Menkel M Eilers, et al. 2001 Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter Genes Dev 15 16 2042 2047 11511535 10.1101/gad.907901 1:CAS:528:DC%2BD3MXmt1ajs7g%3D (Pubitemid 32762047)
5. HK Choi BC Choi SH Lee JW Kim KY Cha KH Baek 2003 Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients Mol Reprod Dev 66 1 24 31 12874795 10.1002/mrd.10331 1:CAS:528:DC%2BD3sXmt1Giurk%3D (Pubitemid 36927783)
6. CV Dang KA O'Donnell KI Zeller T Nguyen RC Osthus F Li 2006 The c-Myc target gene network Semin Cancer Biol 16 4 253 264 16904903 10.1016/j.semcancer. 2006.07.014 1:CAS:528:DC%2BD28XpsVWksb8%3D (Pubitemid 44311039)
7. AP Feinberg B Tycko 2004 The history of cancer epigenetics Nat Rev Cancer 4 2 143 153 14732866 10.1038/nrc1279 1:CAS:528:DC%2BD2cXks1CktA%3D%3D (Pubitemid 38198742)
8. SR Frank M Schroeder P Fernandez S Taubert B Amati 2001 Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation Genes Dev 15 16 2069 2082 11511539 10.1101/gad.906601 1:CAS:528:DC%2BD3MXmt1ajsL0%3D (Pubitemid 32762051)
9. M Giannattasio F Lazzaro P Plevani M Muzi-Falconi 2005 The DNA damage checkpoint response requires histone H2B ubiquitination by Rad6-Bre1 and H3 methylation by Dot1 J Biol Chem 280 11 9879 9886 15632126 10.1074/jbc.M414453200 1:CAS:528:DC%2BD2MXit1eruro%3D (Pubitemid 40395835)
10. GV Glinsky 2005 Death-from-cancer signatures and stem cell contribution to metastatic cancer Cell Cycle 4 9 1171 1175 16082216 10.4161/cc.4.9.2001 1:CAS:528:DC%2BD28XktVCgtL4%3D (Pubitemid 41365385)
11. GV Glinsky 2006 Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway Cell Cycle 5 11 1208 1216 16760651 10.4161/cc.5.11.2796 1:CAS:528:DC%2BD28XnvFWqtb4%3D (Pubitemid 43845382)
12. GV Glinsky O Berezovska AB Glinskii 2005 Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer J Clin Invest 115 6 1503 1521 15931389 10.1172/JCI23412 1:CAS:528:DC%2BD2MXkvF2mu70%3D (Pubitemid 40814659)
13. I Guney S Wu JM Sedivy 2006 Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a) Proc Natl Acad Sci USA 103 10 3645 3650 16537449 10.1073/pnas.0600069103 1:CAS:528:DC%2BD28XivFWju7s%3D (Pubitemid 43376609)
14. K Ingvarsdottir NJ Krogan NC Emre A Wyce NJ Thompson A Emili, et al. 2005 H2B ubiquitin protease Ubp8 and Sgf11 constitute a discrete functional module within the Saccharomyces cerevisiae SAGA complex Mol Cell Biol 25 3 1162 1172 15657441 10.1128/MCB.25.3.1162-1172.2005 1:CAS:528:DC%2BD2MXptFyqug%3D%3D (Pubitemid 40165821)
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):134
16. PA Jones SB Baylin 2007 The epigenomics of cancer Cell 128 4 683 692 17320506 10.1016/j.cell.2007.01.029 1:CAS:528:DC%2BD2sXis12ju7k%3D (Pubitemid 46273572)
17. HJ Lee MS Kim JM Shin TJ Park HM Chung KH Baek 2006 The expression patterns of deubiquitinating enzymes, USP22 and Usp22 Gene Expr Patterns 6 3 277 284 16378762 10.1016/j.modgep.2005.07.007 1:CAS:528:DC%2BD28XhsFyrur4%3D (Pubitemid 43257215)
18. Liu YL, Yang YM, Xu H, Dong XS (2011) Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer. J Surg Oncol 103(3):283-289
19. L Lv XY Xiao ZH Gu FQ Zeng LQ Huang GS Jiang 2011 Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells Mol Cell Biochem 346 1-2 11 21 20824490 10.1007/s11010-010-0585-4 1:CAS:528:DC%2BC3cXhsFSmurrO
20. EA Rakha ME El-Sayed AR Green AH Lee JF Robertson IO Ellis 2007 Prognostic markers in triple-negative breast cancer Cancer 109 1 25 32 17146782 10.1002/cncr.22381 1:CAS:528:DC%2BD2sXhtVKrtLY%3D (Pubitemid 46120191)
21. JS Ross JA Fletcher GP Linette J Stec E Clark M Ayers, et al. 2003 The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy Oncologist 8 4 307 325 12897328 10.1634/theoncologist.8-4-307 1:CAS:528:DC%2BD3sXmvFSqt74%3D (Pubitemid 36929717)
22. JK Stephen LE Vaught KM Chen S Sethi V Shah MS Benninger, et al. 2007 Epigenetic events underlie the pathogenesis of sinonasal papillomas Mod Pathol 20 10 1019 1027 17673925 10.1038/modpathol.3800944 1:CAS:528:DC%2BD2sXhtVCku77J (Pubitemid 47429202)
23. P Su Q Zhang Q Yang 2010 Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue Diagn Pathol 5 38 20565850 10.1186/1746-1596-5-38
24. B Weigelt LF Wessels AJ Bosma AM Glas DS Nuyten YD He, et al. 2005 No common denominator for breast cancer lymph node metastasis Br J Cancer 93 8 924 932 16189523 10.1038/sj.bjc.6602794 1:CAS:528:DC%2BD2MXhtV2kt7vK (Pubitemid 41487019)
25. A Wyce T Xiao KA Whelan C Kosman W Walter D Eick, et al. 2007 H2B ubiquitylation acts as a barrier to Ctk1 nucleosomal recruitment prior to removal by Ubp8 within a SAGA-related complex Mol Cell 27 2 275 288 17643376 10.1016/j.molcel.2007.01.035 1:CAS:528:DC%2BD2sXovFamtbw%3D (Pubitemid 47058302)
26. X Zhang A Kolaczkowska F Devaux SL Panwar TC Hallstrom C Jacq, et al. 2005 Transcriptional regulation by Lge1p requires a function independent of its role in histone H2B ubiquitination J Biol Chem 280 4 2759 2770 15528187 10.1074/jbc.M408333200 1:CAS:528:DC%2BD2MXmt1ymsw%3D%3D (Pubitemid 40189383)
27. XY Zhang HK Pfeiffer AW Thorne SB McMahon 2008 USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A Cell Cycle 7 11 1522 1524 18469533 10.4161/cc.7.11.5962 1:CAS:528:DC%2BD1cXptF2ntb0%3D (Pubitemid 351881314)
28. XY Zhang M Varthi SM Sykes C Phillips C Warzecha W Zhu, et al. 2008 The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression Mol Cell 29 1 102 111 18206973 10.1016/j.molcel.2007.12.015
29. Y Zhao G Lang S Ito J Bonnet E Metzger S Sawatsubashi, et al. 2008 A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing Mol Cell 29 1 92 101 18206972 10.1016/j.molcel.2007.12.011 1:CAS:528:DC%2BD1cXhtlWjtL0%3D